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Background. Topical application of manuka honey is effective in the treatment of burns and soft-tissue infections. The aim
of this study was to assess the antibacterial activity of manuka honey against plaque-associated bacteria in vitro in order to
evaluate the potential application as an adjunct to periodontal treatment. Materials and Methods. The minimum bacteriostatic
and bactericidal concentrations (MIC andMBC) of manuka honey were compared to those of white clover honey against a variety
of plaque-associated bacteria, at the natural and neutral pH. Dissolved calcium was measured following incubation of honeys with
hydroxyapatite (HA) beads to assess their potential to demineralise oral hard tissues.Results. Both honeys inhibitedmost tested oral
bacteria at similar MIC/MBC, but Streptococcus mutans was comparatively resistant. The honeys at pH neutral had little effect on
antimicrobial activity. Incubation of HA beads in honey solutions resulted in pH-dependent calcium dissolution, and inoculation
with S. mutans promoted further demineralisation by both types of honey. Conclusion. Manuka honey is antimicrobial towards
representative oral bacteria. However, the relative resistance of S. mutans in association with the high concentrations of fermentable
carbohydrates in honey and the direct demineralising effect at natural pH mitigate against the application of honey as an adjunct
in the treatment of periodontal disease.
1. Introduction
Honey has been used since ancient times in many cultures
to treat infections and other medical conditions [1, 2]. Since
the 1990s, research on honeys has regained momentum, with
focus towards antibacterial properties particularly against
bacteria associated with antibiotic-resistance and infected
wounds [3–5]. This has led to approval for use of manuka
honey in the treatment of infected wounds, burns, and ulcers
[6–9]. Furthermore, with increasing bacterial resistance to
antimicrobials used in periodontal therapy [10, 11], there
is a requirement to explore alternatives to conventional
antibiotics.
The antibacterial factors in honey include the hyperosmo-
larity effect (>80% sugar content), acidic pH, hydrogen per-
oxide, methylglyoxal, bee defensin-1, various proteinaceous
compounds, flavonoids, and phenolic compounds [4, 12, 13],
but the principal antimicrobial activity of most honeys is
due to hydrogen peroxide [14].Medical-grademanuka honey,
derived from the shrub Leptospermum scoparium (native
to New Zealand and Australia), contains unusually high
concentrations of methylglyoxal and only trace amounts of
hydrogen peroxide [12, 13, 15].
Nonperoxide antibacterial activity (NPA) (commercially
registered as Unique Manuka Factor [UMF]) indicates the
antibacterial efficacy against Staphylococcus aureus, expressed
as the equivalent phenol concentration [16]. The antimicro-
bial activity of honeys varies depending on botanical, geo-
graphical, and seasonal conditions. In New Zealand, manuka
honey with elevated antimicrobial activity is harvested from
select regions in the North Island, particularly East Cape,
Waikato, and Bay of Plenty [17].
Manuka honey has antimicrobial activity in vitro towards
a variety of bacteria including dental plaque-associated bac-
teria, both as planktonic and biofilm organisms [18–20]. Por-
phyromonas gingivalis, which is associated with various peri-
odontal diseases [21], and Aggregatibacter actinomycetem-
comitans, associated with aggressive periodontitis [22], are
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sensitive to manuka honey when grown as planktonic bac-
teria [23, 24] but P. gingivalis is considerably more resistant
when cultivated as a biofilm [25]. English et al. [26] reported
reduced plaque accumulation and gingival bleeding among
human participants with gingivitis after chewing manuka
honey strips for ten minutes daily for 21 days, suggesting
beneficial application of manuka honey as an oral health
aid.
The aim of this study was to assess the antibacterial
activity of medical-grade manuka honey in vitro against
dental plaque-associated bacteria. Manuka honey has a pH <
4 and is principally composed of fermentable carbohydrate
which may mitigate against direct application adjacent to
mineralised oral tissues. Thus, to explore the potential of
manuka honey as a locally delivered subgingival clinical
adjunct in the treatment of chronic periodontitis, we also
evaluated the demineralising potential of honey.
2. Materials and Methods
2.1. Bacterial Strains and Culture Conditions. Staphylococcus
aureus Oxford, Escherichia coli DH5𝛼, Streptococcus mutans
UA159, Streptococcus mutans ATCC 10449, Streptococcus
sobrinus OMZ 176, Streptococcus sanguinis ATCC 10556,
Streptococcus gordonii ATCC 10558, Fusobacterium nuclea-
tum ATCC: 10953, 25586, 33568, 49256; Porphyromonas
gingivalisATCC33277, andPrevotella intermediaATCC25611
were from the University of Otago culture collection. Staph.
aureus and E. coli were included as reference gram-positive
and gram-negative bacteria, respectively [27, 28].
Staph. aureus andE. coliwere cultured in tryptic soy broth
(TSB) (BactoTM, Becton Dickinson Co., Sparks, MD, USA)
and on TSB agar, under aerobic conditions. Streptococci
were cultured on Columbia sheep-blood agar (CBA) (Fort
Richard, Mt. Wellington, New Zealand) under anaerobic
conditions (10% H
2
, 5% CO
2
, and 85% N
2
) in a MACS
work station (MG500, Don Whitley Scientific Ltd., Shipley,
United Kingdom) and were grown in brain heart infusion
(BHI) (Difco Laboratories, Detroit, MI, USA). F. nucleatum,
P. gingivalis, and P. intermedia were cultured and maintained
under anaerobic conditions on CBA and in prereduced
BHI supplemented with hemin chloride (5𝜇g/ml; Sigma
Chemical Co., St. Louis, MO, USA) and menadione (1 𝜇g/ml;
Sigma). All incubations were at 37∘C.
2.2. Honey Preparations. Medical-grade manuka honey
(NPA20+ and NPA25+, Comvita New Zealand Ltd., Bay of
Plenty, New Zealand) and nonmedical grade white clover
honey (HollandsNZHoney Ltd., Timaru,NewZealand)were
purchased from local retailers. Each honey was dissolved
in culture medium to 50% (w/v), filter-sterilised (0.22 𝜇m;
MillexGP,MerckMillipore Ltd., Carrigtwohill, Ireland), and
further diluted in sterile medium. Honey/culture medium
preparations were adjusted to pH 7.1 (±0.05) by adding
calcium hydroxide (Sigma Aldrich, St. Louis, MO, USA)
using a microprocessor pH meter (pH211 with HI 1230B
electrode, Hanna Instruments, Woonsocket, RI, USA). The
pH-adjusted honey preparations were filter-sterilised and
diluted in culture media.
2.3. Bacteriostatic and Bactericidal Assays. Minimum inhi-
bitory concentration (MIC) and minimum bactericidal con-
centration (MBC) assays were performed according to CLSI
reference methods for bacteria [29]. Assays were prepared
in 96-well flat-bottomed microtitre trays, each well con-
taining 200𝜇L of honey preparation inoculated with 10 𝜇L
of bacterial culture adjusted to a McFarland standard of
0.5. The MICs were determined by optical density (𝐴
600
)
measurement (Biotek Instruments Synergy 2, Vermont, NE,
USA) and MBCs by spot-plating 10 𝜇L onto appropriate agar
followed by incubation (as above). MBC was determined as
the lowest concentration resulting in complete killing of the
test bacterium.TheMBC assay was adapted to determine the
rapidity of killing by removing and plating samples at specific
times.
2.4. Demineralisation Assay. The honeys were dissolved in
distilled water at 50% (w/v), and 1mL was added to 10mg
of hydroxyapatite (HA) beads (particle size of 80𝜇m; Bio-
Rad Laboratories, Hercules, CA, USA). Hydrochloric acid
(0.1M) and distilled water were used as positive and negative
demineralisation controls, respectively. After incubation for
24 h, supernatants were recovered and solubilised calcium
measured with a colorimetric detection assay kit (Abcam
Australia Pty Ltd., Melbourne, Australia) according to the
manufacturer’s directions. Honey preparations (without HA
beads) were assayed to determine intrinsic calcium concen-
trations which were subtracted from the demineralisation
assays.
The demineralisation assay was modified to assess the
additional influence of S. mutans. Honey dilutions were
prepared in TSB without dextrose (TSB w/o D; Difco) and
1mL was added to each tube containing sterilised HA beads
(10mg). An aliquot (50 𝜇L) of S. mutans (grown for 18 h in
TSBw/oD)was used to inoculate the honey/HApreparations
whichwere incubated for 24 hours. Supernatant sampleswere
analysed for solubilised calcium.
3. Results
3.1. Bacteriostatic and Bactericidal Activities of Honeys. Nei-
ther manuka nor clover honey exhibited antibacterial effects
within four-hour exposure to bacteria. With the exception
of S. mutans, all tested bacteria were inhibited by both types
of honey after 18 h incubation (Figure 1). Manuka honey dis-
played slightly greater inhibitory efficacy, with MICs ranging
between 6.3% and 25%, whereas the MICs of clover honey
ranged from 6.3% to 50% (Figure 1). Manuka honey was
slightly more acidic than clover honey (Figure 1).
The MBCs of manuka honey showed a range of between
12.5% and 50% (w/v) and clover honey from 6.3% to 50%
(Table 1; Figure 2). S. mutans was the most resistant of the
tested species against both types of honey (Table 1) but
was killed by manuka honey (NPA25+) at 50% (Figure 2).
The bactericidal activity of both types of honey required
18 h exposure (Table 1; Figure 2). Following adjustment of
the pH to neutrality, the bactericidal activity of manuka
honey was largely maintained (Table 1; Figure 2(a)) whereas
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Figure 1: Continued.
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Figure 1: Minimum inhibitory concentrations (% w/v) of manuka and white clover honeys against various bacteria after 18 h incubation. pH
of honey dilutions is recorded (a). Bacterial growth was determined as culture density (𝐴
600
) in a microtitre-plate reader. F. nucleatum: ATCC
25586.
Table 1: Minimum bactericidal concentrations (MBC) of manuka (NPA 20+) and white clover honeys against a variety of bacteria.
Bacteria
MBC (% w/v)
Manuka honey NPA20+ White clover honey
pH 4.9∗ pH 7.1 pH 5.2∗ pH 7.1
Staph. aureus 12.5 12.5 50 >50
E. coli 12.5 25 25 50
S. mutans UA159 >50 >50 >50 >50
S. mutans 10449 25 25 25 50
S. sobrinus 12.5 12.5 25 25
S. sanguinis 25 25 50 50
S. gordonii 25 25 25 >50
F. nucleatum ATCC 25586 12.5 12.5 25 25
F. nucleatum ATCC 33568 25 25 25 25
P. gingivalis 12.5 12.5 12.5 25
P. intermedia 12.5 12.5 25 12.5
P. gingivalis and P. intermedia were incubated for 48 h while all other bacteria were incubated for 18 h. The highest honey concentration tested was 50% (w/v).
NPA: nonperoxide antibacterial activity.
∗Natural pH at 50% (w/v) in culture media.
pH-adjusted clover honey exhibited varying bactericidal
activity (Table 1).
3.2. Demineralisation of HA Beads Incubated in Honey.
Incubation of HA beads in dilute honey resulted in signif-
icant solubilisation of calcium as compared to incubation
in water. The two types of honey did not differ signifi-
cantly in this respect (Figure 3(a)). Demineralisation also
occurred when honey/HA preparations were maintained at
4∘C (Figure 3(a)), suggesting that the effect was due to low
pH rather than biological activity.
When the assay was modified by the addition of S.
mutans, both types of honey promoted significant dem-
ineralisation at lower concentrations (Figure 3(a)) and cal-
cium solubilisation was positively correlated to [H+] (𝑝 <
0.01) (Figure 3(b)). Decalcification decreased as the honey
concentrations increased, due to the antibacterial effects of
the honey (Figure 3(a)).
4. Discussion
A few clinical studies have reported reduction in plaque
accumulation and gingival bleeding [26, 30] and decreased
proportion of mutans streptococci [31] with application
of honey intraorally, supporting the use of honey as an
oral antimicrobial agent. Thus, the present preclinical study
assessed the potential for subgingival application of manuka
honey in the treatment of periodontal diseases.
Both manuka and clover honeys were active against a
variety of organisms including plaque-associated bacteria;
manuka honey was more active in this respect. In agreement
with other studies [24, 28, 32], P. gingivalis, P. intermedia, and
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Figure 2: Bactericidal effect of manuka honey (NPA 25+) against (a) S. mutans and P. gingivalis and (b) effective incubation time of manuka
honey [50% (w/v)] against S. mutans. NPA = nonperoxide antibacterial activity.
F. nucleatum, gram-negative bacteria associated with gingivi-
tis and periodontal diseases, were more sensitive than the
gram-positive species associated with gingival health (strep-
tococci). Subgingival application of manuka honey could
therefore conceivably promote health-associated species at
the expense of those associated with periodontal diseases.
However, S. mutans is generally considered cariogenic [33,
34] and was the most resistant of the tested organisms to
both types of honey. As honey is principally composed of
fermentable carbohydrates including fructose, glucose, and
sucrose [35], localised application of manuka honey could
conceivably select and encourage cariogenic species. Honey
is considered cariogenic when consumed as a foodstuff
[36].
As S.mutans is notably acid-tolerant [37, 38], the question
arises as to whether the low pH of honey contributes to
the antimicrobial effects against other species but adjusting
the pH to neutrality had limited effect on the antimicrobial
activity. The natural pH of honey ranges from 3.1 to 4.5
[12, 39], well below the accepted critical pH of 5.5 for
enamel and more importantly cementum demineralisation
[40, 41] further mitigating against subgingival application
of honey to root surfaces as an adjunct in the treatment of
periodontitis. On the other hand, the evidence for enamel
demineralisation following prolonged in vitro exposure to
honey is contradictory [42–44]. Dilute honey should pose
less of a threat to mineralised tissues but would also have
less antimicrobial activity. Our in vitro findings demonstrate
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Figure 3: (a) Solubilisation of calcium from HA beads following
incubation of S. mutans with manuka and clover honeys at 37∘C
and 4∘C. ∗Significantly different from water control (𝑝 < 0.05; one-
wayANOVAwithDunnett’s post hoc test). (b) Relationship between
solubilised calcium and final proton concentration. Correlation
between calcium solubilisation and [H+] (𝑟
𝑠
= 0.770, 𝑝 < 0.01)
Spearman’s rho test. MH25+: manuka honey NPA25+; MH20+:
manuka honey NPA 20+; CH: clover honey.
that diluting the honey not only reduces the antimicrobial
activity but also promotes bacterial carbohydratemetabolism
and consequent acid production by S. mutans, resulting in
further demineralisation.
Pharmacokinetic studies of subgingivally delivered anti-
microbial agents report exponential concentration reduction
following application [45, 46], implying that the bacterio-
static action of honey will begin to diminish immediately
following delivery to a periodontal pocket. Application of
undiluted honey may have an effective initial antimicrobial
effect but the low pH will facilitate demineralisation of
adjacent cementum and, as the honey concentration falls,
acid production by the surviving bacteria (i.e., fermentative
streptococci) will promote further demineralisation.
Despite evidence that manuka honey provides effective
antimicrobial effects when applied to soft tissues and encour-
aging clinical outcomes for intraoral use, our findings suggest
that it could be damaging to calcified tissues. Nevertheless,
whether a single application (rather than a sustained release)
would deliver a beneficial antimicrobial effect without threat-
ening root integrity remains to be determined. However,
other beneficial oral applications of manuka honey, which
do not threaten the mineralised tissues, might be considered,
for example, to dental implants in the treatment of peri-
implantitis.
5. Conclusion
Medical-grade manuka honey (i.e., NPA > 20) is antimi-
crobial towards representative oral bacteria generally, and
the gram-negative anaerobes associated with gingivitis are
particularly sensitive. However, the relative resistance of
cariogenic S. mutans in association with the high concentra-
tions of fermentable carbohydrates in honey and the direct
demineralisation of oral hard tissues caused by the low pH of
honeymitigate against application as a subgingival sustained-
release adjunct in the treatment of periodontal disease.
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